Navigation Links
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Date:1/29/2010

breakthrough bleeding, while taking Lamictal XR and birth control pills. These are not all the possible side effects of Lamictal XR.

For full prescribing information for Lamictal XR, including Boxed Warning, please visit www.gsk.com.

Editor's Note: About the Clinical Trial

The approval of Lamictal XR (lamotrigine) as add-on therapy for primary generalized tonic-clonic seizures was based upon data from a 19-week, international, multicenter, double-blind, randomized, placebo-controlled study in 143 patients 13 years of age and older (n = 70 on Lamictal XR and n = 73 on placebo). Patients with at least three primary generalized tonic-clonic seizures during an eightweek baseline phase were randomized to 19 weeks of treatment with Lamictal XR or placebo added to their current antiepileptic drug (AED) regimen of up to two drugs. Patients were dosed on a fixed-dose regimen, with target doses ranging from 200 mg/day to 500 mg/day of Lamictal XR based on concomitant AED(s) (target dose = 200 mg for valproate, 300 mg for AEDs not altering plasma lamotrigine, and 500 mg for enzyme-inducing AEDs).

The primary efficacy endpoint was percent change from baseline in primary generalized tonic-clonic seizure frequency during the double-blind treatment phase. For the intent-to-treat population, the median percent reduction in primary generalized tonic-clonic seizure frequency was 75 percent in patients treated with Lamictal XR and 32 percent in patients treated with placebo, a difference that was statistically significant, defined as a two sided p value < 0.05.

The proportion of patients achieving any particular level of reduction in primary
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
2. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
3. FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
4. FDA Approves Lillys ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
5. FDA Approves Lillys Zyprexa for Two Adolescent Indications
6. US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
7. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
8. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
9. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
10. FDA Approves Agriflu Seasonal Influenza Vaccine
11. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  Celsion Corporation ... the Company will host a conference call to ... update on its development programs for ThermoDox®, its ... newly acquired technology platforms, TheraPlas™ and TheraSilence™, in ... on Thursday, March 12, 2015. To participate in ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has ... 2015: Accelerating growth to the next level - Moving ... their offering. Domestic sales improved in ... by the market,s reaction to the new drug pricing ... be healthy, as the momentum continues and improving economic ...
(Date:3/5/2015)... DUBLIN and HAMPTON, N.J. ... (NYSE: MNK ), a leading global ... care company, announced today that they have entered into ... will acquire Ikaria, Inc. from a Madison Dearborn ... $2.3 billion. Subject to customary closing ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... Sept. 15, 2011 Inogen has won a service ... and devices to patients in TRICARE,s 21-state western service ... the Inogen One portable oxygen concentrator to ... TRICARE West (TriWest) covers 2.7 million patients in ...
... N.J., Sept. 15, 2011 Fidia Farmaceutici S.p.A. (Fidia) ... (sodium hyaluronate), an injectable treatment for knee pain ... physical therapy are not enough, will be transferred from ... 2011.  Fidia Farmaceutici S.p.A. is the owner and manufacturer ...
Cached Medicine Technology:Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients 2HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A. 2
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 A Bakersfield, ... a seven-week trial awarding the plaintiff Coleen M. ... as a result of a TVT-Abbrevo pelvic mesh sling device, ... , Tom Cartmell , a partner at Wagstaff ... trial team for the plaintiff, along with Rich Freese and ...
(Date:3/5/2015)... March 05, 2015 Risperdal lawsuits ... a Pennsylvania mass tort litigation currently underway in ... jury has begun hearing testimony in the proceeding’s ... antipsychotic medication can cause gynecomastia, or male breast ... question was filed on behalf of a plaintiff ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
(Date:3/5/2015)... Angeles, CA (PRWEB) March 05, 2015 ... article titled “Butt Augmentation, Labiaplasty on the Rise, Plastic ... reported by the American Society for Aesthetic Plastic ... Surgeons . Both groups reported a year-over-year doubling of ... of the physicians quoted in the article, this increase ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2
... FORT WORTH, Texas, June 15 Female caregivers of African American ... papillomavirus (HPV), according to a new study by the Center for ... Worth, Texas. , , The HPV Vaccine Acceptability Study discovered ... , Most ...
... thread, researcher says , MONDAY, June 15 (HealthDay News) ... major cardiovascular disease and death, a new study finds. ... Administration medical facility study to compare 3,236 people suffering ... a 78 percent higher incidence of heart disease, a ...
... , WASHINGTON, June 15 Just as Congress begins to ... since Medicare became law in 1965, Hudson Institute will debate ... 17th. , , Health costs will define the long-term ... care costs will be the topic of the Hudson panel. ...
... Va., June 15 Escalating funding issues challenge social ... across the country indicate that decreasing funds impact both ... state governments face new budget years a stark reality ... that provide minimal, but essential, services to the country,s ...
... New Pharmacy Benefit Evaluator Analyzes Health Plan Pharmacy Benefit ... Care Sales Strategy Development , , NASHVILLE, Tenn., ... care market intelligence, has enhanced its Pharmacy ... health plan pharmacy benefit structure and spending and the ...
... special interest," says campaign finance watchdog group , ... has spent $204.4 million to influence Congress and Administrations over ... contributions over the last two decades, according to a Public ... Responsive Politics website. , , "When President Obama addresses ...
Cached Medicine News:Health News:HPV Vaccine Acceptability Study Announces Results 2Health News:HPV Vaccine Acceptability Study Announces Results 3Health News:Psoriasis Raises Risk of Heart Attack, Stroke, Death 2Health News:Hudson Institute Debates the Long-Term Fiscal Impact of Health Care Reform 2Health News:Government Must Not Balance Budget on the Backs of the Poor 2Health News:Government Must Not Balance Budget on the Backs of the Poor 3Health News:HealthLeaders-InterStudy Launches Pharmacy Benefit Evaluator 2Health News:Backgrounder: As Obama Makes Pitch to AMA, the Group Tries to Call in its Political Investment in Congress 2
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
... the most comprehensive family of lightweight ... Cataract incision, Glaucoma filtration, and Vitreoretinal ... achieved with minimal tissue trauma and ... styles are available in 18, 20, ...
Medicine Products: